Immunomodulation of local immune response at the oropharyngeal mucosa can hypothetically activate mucosal immunity, which can difficult SARS-CoV-2 main immune evasion mechanisms in early stages of the disease and send an effective warning to the adaptive immune system. There are previous studies on immunotherapeutic management of upper respiratory tract infections with olive polyphenols. The investigators would like to study if participants following oromucosal immunomodulation with tiny quantities of high polyphenolic olive oil (early harvest olive oil) could have more possibilities to have less severe symptoms and a better outcome after SARS-CoV-2 infection.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Enrollment
88
High polyphenolic olive oil is normal olive oil obtained from early harvest olives, this early harvest olive oil has been widely used for culinary purposes for centuries. The investigators wanted to study if oromucosal immunoprophylaxis with small quantities of high polyphenolic olive oil (2 mL of olive oil equivalent to 5 mg of polyphenols) adiministered twice a day could have clinical mitigating effects on the disease caused by SARS-CoV-2 infection.The primary outcome was to determine the effect of high polyphenolic olive oil on Coronavirus disease incidence, duration and severity.
Hospital Nuestra Señora del Prado
Talavera de la Reina, Toledo, Spain
Incidence.
High polyphenolic olive oil immunoprophylaxis intervention and incidence of COVID-19.
Time frame: 3 months.
Duration-
Time to resolution of symptoms of COVID-19 in participants versus normal population.
Time frame: 3 months
Severity.
Differences in severity of symptoms of COVID-19 between participants and control group.
Time frame: 3 months.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.